Her-2 targeting in uterine papillary serous carcinoma.

Gynecol Oncol Case Rep 2012 8;2(3):94-6. Epub 2012 May 8.

Department of Hematology/Oncology, St. Luke's Roosevelt Hospital Center, New York, NY, USA.

► A case of metastatic uterine papillary serous cancer with Her-2 gene amplification. ► Was treated with a Her-2 targeted agent and achieved durable remission. ► Her-2 targeting should be considered alone or in combination with chemotherapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gynor.2012.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860722PMC
December 2013
1 Read

Publication Analysis

Top Keywords

papillary serous
8
uterine papillary
8
her-2 targeting
8
treated her-2
4
targeted agent
4
her-2 targeted
4
► treated
4
her-2
4
amplification ►
4
agent achieved
4
her-2 gene
4
durable remission
4
considered combination
4
combination chemotherapy
4
targeting considered
4
► her-2
4
cancer her-2
4
remission ►
4
achieved durable
4
gene amplification
4

Similar Publications